Analysts Anticipate Xylem Inc. (XYL) Will Announce Earnings of $0.57 Per Share
Brokerages forecast that Xylem Inc. (NYSE:XYL) will post earnings of $0.57 per share for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Xylem’s earnings, with estimates ranging from $0.56 to $0.58. Xylem reported earnings of $0.48 per share during the same quarter last year, which suggests a positive year over year growth rate of 18.8%. The business is expected to report its next quarterly earnings report before the market opens on Tuesday, August 1st.
According to Zacks, analysts expect that Xylem will report full year earnings of $2.32 per share for the current fiscal year, with EPS estimates ranging from $2.26 to $2.36. For the next fiscal year, analysts forecast that the firm will post earnings of $2.66 per share, with EPS estimates ranging from $2.60 to $2.71. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Xylem.
Xylem (NYSE:XYL) last posted its earnings results on Tuesday, May 2nd. The industrial products company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.05 billion. Xylem had a net margin of 6.75% and a return on equity of 15.53%. The firm’s quarterly revenue was up 26.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.35 earnings per share.
Several research analysts have issued reports on XYL shares. Barclays PLC raised shares of Xylem from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $51.00 to $59.00 in a research report on Monday, May 15th. CIBC reissued a “buy” rating and set a $58.00 price objective on shares of Xylem in a research report on Thursday, April 6th. Oppenheimer Holdings, Inc. set a $58.00 price objective on shares of Xylem and gave the stock a “buy” rating in a research report on Wednesday, April 5th. BidaskClub raised shares of Xylem from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Finally, BMO Capital Markets started coverage on shares of Xylem in a research report on Wednesday, June 21st. They set an “outperform” rating and a $60.00 price objective on the stock. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $56.85.
In other news, Director Steven R. Loranger sold 66,132 shares of the firm’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the sale, the director now owns 65,030 shares in the company, valued at approximately $3,577,300.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Tomas Brannemo sold 14,080 shares of the firm’s stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $50.36, for a total transaction of $709,068.80. Following the completion of the sale, the insider now owns 21,000 shares of the company’s stock, valued at approximately $1,057,560. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by company insiders.
Hedge funds have recently made changes to their positions in the stock. Asset Planning Services Ltd. boosted its stake in shares of Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock valued at $106,000 after buying an additional 7 shares during the period. Contravisory Investment Management Inc. boosted its stake in shares of Xylem by 96.1% in the first quarter. Contravisory Investment Management Inc. now owns 2,345 shares of the industrial products company’s stock valued at $118,000 after buying an additional 1,149 shares during the period. Cribstone Capital Management LLC boosted its stake in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock valued at $124,000 after buying an additional 2,247 shares during the period. CENTRAL TRUST Co boosted its stake in shares of Xylem by 160.3% in the second quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock valued at $146,000 after buying an additional 1,635 shares during the period. Finally, FNY Partners Fund LP bought a new stake in shares of Xylem during the first quarter valued at approximately $151,000. Hedge funds and other institutional investors own 85.91% of the company’s stock.
Xylem (NYSE XYL) opened at 57.62 on Monday. The firm has a market capitalization of $10.36 billion, a P/E ratio of 41.45 and a beta of 1.18. Xylem has a 52-week low of $45.60 and a 52-week high of $57.66. The company’s 50-day moving average is $54.55 and its 200-day moving average is $50.91.
WARNING: “Analysts Anticipate Xylem Inc. (XYL) Will Announce Earnings of $0.57 Per Share” was first published by American Banking News and is the property of of American Banking News. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/07/24/analysts-anticipate-xylem-inc-xyl-will-announce-earnings-of-0-57-per-share.html.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.